本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

FibroGen, Inc

12.18
+0.35002.96%
盘后12.200.0194+0.16%18:07 EDT
成交量:11.38万
成交额:131.25万
市值:4,925.47万
市盈率:-23.78
高:12.18
开:11.97
低:10.98
收:11.83
52周最高:21.94
52周最低:4.50
股本:404.39万
流通股本:362.37万
量比:4.46
换手率:3.14%
股息:- -
股息率:- -
每股收益(TTM):-0.5122
每股收益(LYR):-11.8895
净资产收益率:-1015.79%
总资产收益率:-16.40%
市净率:-0.22
市盈率(LYR):-1.02

数据加载中...

2023/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/07

重要事件披露

8-K - Current report
2022/11/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/17

重要事件披露

8-K - Current report
2022/06/08

重要事件披露

8-K - Current report
2022/05/09

重要事件披露

8-K - Current report
2022/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/03/04

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/28

重要事件披露

8-K - Current report
2022/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals